Skip to main content

Advertisement

Table 2 The values of coronary flow rate (ml/min) in the experimental groups

From: Myocardial protection against global ischemia with Krebs-Henseleit buffer-based cardioplegic solution

Groups Baseline Reperfusion, min
   5 30 60 120
CON-22 (n=7) 11.9±2.3 3.8±1.5 5.4±1.6 6.5±1.9 5.8±2.6
mKHB-22 (n=7) 10.2±2.6 4.5±2.3 6.7±1.6 6.1±1.8 4.2±1.7
STH2-22 (n=6) 13.2±3.5 5.3±2.5 6.7±2.2 7.5±4.6 5.5±2.1
CON-37 (n=7) 12.4±3.2 4.1±1.3 4.3±1.9 4.1±1.7 3.8±1.2
mKHB-37 (n=5) 10.4±1.9 6.6±4.0 6.2±1.7 6.3±0.6 5.2±1.4
STH2-37 (n=6) 11.2±1.8 5.6±3.9 4.6±2.1 3.3±0.7 3.1±0.9
  1. Data are mean ± SD. Group legends in hypothermia series: controls subjected to 180-min ischemia and 120-min reperfusion (CON-22), cardioplegia with modified Krebs-Henseleit buffer-based cardioplegic solution (mKHB-22), cardioplegia with St Thomas’ Hospital cardioplegic solution №2 (STH2-22). Group legends in normothermia series: controls subjected to 60-min ischemia and 120-min reperfusion (CON-37), cardioplegia with modified Krebs-Henseleit buffer-based cardioplegic solution (mKHB-37), cardioplegia with St Thomas’ Hospital cardioplegic solution №2 (STH2-37).